Simplex Trading
LUMO

Simplex Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Simplex Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,002
Closed -$42.8K – 8116
2019
Q3 		$42K Buy
+3,002
New +$44K ﹤0.01% 5187
2019
Q2 		– Sell
-971
Closed -$14.7K – 7960
2019
Q1 		$16K Buy
971
+560
+136% +$8.35K ﹤0.01% 5864
2018
Q4 		$5K Sell
411
-1,006
-71% -$17.7K ﹤0.01% 6250
2018
Q3 		$30K Buy
+1,417
New +$43.1K ﹤0.01% 5651
2018
Q1 		– Sell
-26
Closed -$1.84K – 7025
2017
Q4 		$1K Sell
26
-7,340
-100% -$607K ﹤0.01% 5681
2017
Q3 		$674K Buy
+7,366
New +$565K 0.03% 525
2017
Q2 		– Sell
-7,121
Closed -$882K – 6933
2017
Q1 		$1.54M Buy
7,121
+5,595
+367% +$799K 0.07% 262
2016
Q4 		$141K Buy
+1,526
New +$172K 0.01% 1281
2016
Q2 		– Sell
-2,510
Closed -$311K – 6580
2016
Q1 		$411K Buy
+2,510
New +$509K 0.03% 525
2015
Q1 		– Sell
-326
Closed -$126K – 5736
2014
Q4 		$117K Buy
+326
New +$97K 0.01% 850

Other funds holding LUMO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Simplex Trading's LUMO Position: Q4 2019 in Review

Simplex Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2019, closing a stake of 3,002 shares — an estimated $42.8K sold.

Simplex Trading first reported a position in LUMO in Q4 2014 and held it in 10 quarters. The position peaked at $1.54M in Q1 2017. 64 funds tracked by Wall St. Rank hold LUMO as of Q4 2019.

  • Simplex Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Simplex Trading sold 3,002 Lumos Pharma, Inc. Common Stock shares in Q4 2019, an estimated $42.8K.
  • Simplex Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Lumos Pharma, Inc. Common Stock position peaked at $1.54M in Q1 2017.
  • 64 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2019.

Based on Simplex Trading's 13F filing for Q4 2019, filed 5 Feb 2020.